Cargando…
Thiazide diuretics are back in CKD: the case of chlorthalidone
Sodium and volume excess is the fundamental risk factor underlying hypertension in chronic kidney disease (CKD) patients, who represent the prototypical population characterized by salt-sensitive hypertension. Low salt diets and diuretics constitute the centrepiece for blood pressure control in CKD....
Autores principales: | Minutolo, Roberto, De Nicola, Luca, Mallamaci, Francesca, Zoccali, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871852/ https://www.ncbi.nlm.nih.gov/pubmed/36726437 http://dx.doi.org/10.1093/ckj/sfac198 |
Ejemplares similares
-
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023) -
Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing
por: Zoccali, Carmine, et al.
Publicado: (2023) -
What is central to renal nutrition: protein or sodium intake?
por: Wang, Angela Yee-Moon, et al.
Publicado: (2023) -
Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics()
por: Pareek, Anil, et al.
Publicado: (2020) -
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)